We suggest measuring cholinergic index, i.e., ratio of ChAT/AChE (acetylcholinesterase) in the CSF, as a potential biomarker for diagnosing cognitive dysfunction in people with T1DM. This evidence concerns the gene ACHE and type 1 diabetes mellitus.